Ventricular arrhythmias. An assessment of newer therapeutic agents.
Skluth
H
H
Department of Pharmacy Practice, College of Pharmacy, University of Florida, Gainesville.
Grauer
K
K
Gums
J
J
D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D005424:Flecainide / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008801:Mexiletine / Q000627:therapeutic use; D016677:Tocainide; D014481:United States
D000889:Anti-Arrhythmia Agents; D008801:Mexiletine; D016677:Tocainide; D008012:Lidocaine; D005424:Flecainide; D000638:Amiodarone